News
The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...
Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...
Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...
Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...
Mar Vista U.S. Quality Select Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its Q1 2025 investor ...
The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...
Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...
Wall Street teetered toward small losses in relatively calm trading Tuesday morning after President Donald Trump appeared to ...
A Fox Business correspondent turned heads with a scoop about a possible tariff deal between the U.S. and India.
Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.
Kenvue (KVUE) stock spikes as activist investor Third Point Capital takes a stake, sparking renewed scrutiny on the J&J (JNJ) ...
The Trump administration has been quietly tipping off Wall Street executives about the progress of tariff negotiations ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results